Strategic Divestiture and Financial Flexibility: HLS Therapeutics Inc's Optimistic Buy Rating

TipRanksJul 3 08:35 ET

Stifel Nicolaus Keeps Their Hold Rating on HLS Therapeutics Inc (HLS)

TipRanksJul 3 07:46 ET

Stocks in Play: HLS Therapeutics Inc.

Baystreet.caMay 28 10:00 ET

New Study Published on the Impact of Pharmaceutical Support Programs on Persistence With Clozapine Treatment

Stockhouse May 28 06:30 ET

HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance

HLS Therapeutics (HLS.TO) reported a wider first quarter net loss than in the year earlier period as revenue fell. The company has also terminated its agreement with Pfizer. The pharmaceutical compan

MT NewswiresMay 9 07:56 ET

Press Release: HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call

HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO, April 25, 2024 TORONTO, April 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX

Dow JonesApr 25 08:50 ET